Cushing’s syndrome is a disorder that occurs when your body makes too much of the hormone cortisol over a long period of time. Cortisol is sometimes called the “stress hormone” because it helps your body respond to stress.
Numerous studies have suggested that hypercortisolism is present in 3-8 percent of unselected patients with type 2 diabetes mellitus. Recent data from the Catalyst study suggest that hypercortisolism may be seen in as many as one-quarter of patients with uncontrolled type 2 diabetes…
The CSRF has published materials from their recent Patient Journey Summit,”Defining the New Normal” The topics for the conference, held October 4-6, 2019 at Emory Conference Center Hotel in Atlanta, were organized by a patient-led group. The group
The World Alliance of Pituitary Organizations (WAPO) will participate in the upcoming Cushing’s Support and Research Foundation (CSRF) conference slated for October 4 to 6 in Atlanta, Georgia. Muriel Marks, WAPO’s Executive Director, will present
In a press release, Strongbridge Biopharma announced comprehensive positive results of their Phase 3 SONICS study of RECORLEVTM (levoketoconazole) for the potential treatment of endogenous Cushing’s syndrome. The results were published online in The Lancet
Our podcast today is on silent pituitary adenomas. This is a fascinating look into these tumors that are thought not to secrete hormones. In the podcast Dr. Blevins discusses the complexities and challenges when dealing
Why is it important to know about the symptoms of hypercortisolism and its clinical consequences? And why is early detection so critical? The answers to these vital questions are highlighted in a new web resource
In this podcast, Dr. Blevins reviews a study conducted at the Ludwig Maximilian University of Munich, Germany on pituitary tumor therapeutics and the treatment for tumors that produce ACTH and cause Cushing’s. Dr. Blevins reviews
From Lewis S. Blevins Jr. M.D. – This interesting manuscript – BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY – reports the outcomes data of management of
In this podcast, we discuss the latest data on the incidence of Cushing’s disease worldwide based on a recent Swedish study on the subject, and the importance of disease awareness in early diagnosis.
Daphne Adelman is a clinical nurse specialist at Northwestern University. In her job at Northwestern, she manages and coordinates studies for pharmaceutical and National Institutes for Health-sponsored studies. Daphne’s work focuses on pituitary conditions like
In today’s podcast, Dr. Blevins focuses on a discussion of disorders of ACTH or Adrenocorticotropic Hormone in two recent cases from his practice. Adrenocorticotropic hormone (ACTH) is a hormone produced in the anterior, or front,
In this informative podcast, Dr. Lewis Blevins explores the long-term issues affecting people with Cushing’s disease and syndrome. For more information on Cushing’s download this series of podcasts. Music by Patrick Muecke
Today’s podcast is on ACTH producing pituitary adenomas. Dr. Blevins discusses the different factors and theories that lead to the development of these tumors, challenges in diagnosis and treatment. The podcast also highlights a few very interesting cases.